Key result
Inotropic stimulation with dobutamine during coronary occlusion increased acute myocardial ischemic injury (delta PmCO2 76 vs 56 mm Hg, p<0.01) only when heart rate was simultaneously increased.
Why the study?
Does intravenous dobutamine exacerbate acute myocardial ischemic injury in an anesthetized dog model of coronary occlusion?
Population
22 anesthetized dogs subjected to serial 10-minute occlusions of the left anterior descending coronary artery
Comparison
Intravenous dobutamine at varying doses vs Control occlusion without dobutamine, with or…
Design
Preclinical
Authors
Loading...
Dobutamine with concurrent tachycardia may worsen acute ischemic injury; leaves open whether isolated inotropy is neutral.
Does intravenous dobutamine exacerbate acute myocardial ischemic injury in an anesthetized dog model of coronary occlusion?
Absolute Event Rate: 76% vs 56%
p-value: p=<0.01
Inotropic stimulation with dobutamine does not significantly worsen acute myocardial ischemic injury in the nonfailing heart unless it simultaneously increases heart rate.
Rude et al. (1982) studied Acute myocardial ischemic injury (n=22). Dobutamine vs. Control occlusion was evaluated on Increase in intramural carbon dioxide tension (delta PmCO2) in the ischemic zone (p=<0.01). Inotropic stimulation with dobutamine during coronary occlusion increased acute myocardial ischemic injury (delta PmCO2 76 vs 56 mm Hg, p<0.01) only when heart rate was simultaneously increased.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: